Nomogram to Predict Progression-free Survival in Patients with Well-differentiated, Stage IV Gastroenteropancreatic Neuroendocrine Tumors Treated with Somatostatin Analogues: Data of TRASGU-GETNE Study

被引:0
|
作者
Jimenez-Fonseca, P. [1 ]
Alonso, V [2 ]
Riesco, M. C. [3 ]
Custodio, A. [4 ]
Molina-Cerrillo, J. [5 ]
Sanchez Canovas, M. [6 ]
Benavent, M. [7 ]
Hernando Cubero, J. [8 ]
La Casta, A. [9 ]
Lopez, C. [10 ]
Marazuela Azpiroz, M. [11 ]
Carmona-Bayonas, A. [12 ]
机构
[1] Hosp Univ Cent Asturias, Dept Med Oncol, Oviedo, Spain
[2] Hosp Univ Miguel Servet, Dept Med Oncol, Zaragoza, Spain
[3] Hosp Univ Doce Octubre, Dept Med Oncol, Madrid, Spain
[4] Hosp Univ La Paz, Dept Med Oncol, Madrid, Spain
[5] Hosp Univ Ramon & Cajal, Dept Med Oncol, Madrid, Spain
[6] Hosp Univ Morales Meseguer, Dept Med Oncol, Murcia, Spain
[7] Hosp Univ Virgen Rocio, Dept Med Oncol, Seville, Spain
[8] Hosp Univ Vall dHebron, Dept Med Oncol, Barcelona, Spain
[9] Hosp Univ Donostia, Dept Med Oncol, San Sebastian, Spain
[10] Hosp Univ Marques Valdecilla, Dept Med Oncol, Santander, Spain
[11] Complejo Hosp La Princesa, Dept Endocrinol, Madrid, Spain
[12] Univ Murcia, Hosp Univ Morales Meseguer Murcia, Dept Med Oncol, UMU,IMIB, Murcia, Spain
关键词
cox regression; prognosis; registry; tool;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
D28
引用
收藏
页码:67 / 67
页数:1
相关论文
共 31 条
  • [31] Impact of Prior Somatostatin Analogue (SSA) Use on Progression-free Survival (PFS) in Patients With Advanced Nonfunctional Neuroendocrine Tumors (NET) of Lung or Gastrointestinal (GI) Origin: A Secondary Analysis from the RADIANT-4 Study
    Buzzoni, Roberto
    Carnaghi, Carlo
    Pommier, Rodney
    Fazio, Nicola
    Singh, Simron
    Voi, Maurizio
    Pacaud, Lida
    Ridolfi, Antonia
    Yao, James
    Wolin, Edward
    Pavel, Marianne
    Strosberg, Jonathan
    PANCREAS, 2017, 46 (03) : 432 - 433